What medications are recommended for treating costochondritis?

Medications for Costochondritis

For costochondritis, start with a 1-2 week trial of NSAIDs (such as ibuprofen or naproxen) at maximum tolerated doses, and add low-dose colchicine if NSAIDs alone provide insufficient relief. 1

First-Line Treatment: NSAIDs

The most direct guideline evidence for costochondritis treatment comes from the 2022 ACC Expert Consensus, which specifically addresses chest pain with an inflammatory component like costochondritis. NSAIDs should be your initial pharmacologic approach, prescribed for 1-2 weeks 1. This aligns with standard anti-inflammatory treatment principles used across musculoskeletal conditions.

Specific NSAID Recommendations:

• Use maximum tolerated doses for adequate anti-inflammatory effect
• Consider ibuprofen, naproxen, or other non-selective NSAIDs as first choice
• For patients with gastrointestinal risk factors, use COX-2 selective inhibitors (celecoxib) with a proton pump inhibitor 2, 3
• Prescribe at the lowest effective dose for the shortest duration to minimize cardiovascular and GI risks 3, 4

Important Safety Considerations:

• Avoid NSAIDs entirely in patients with significant cardiovascular disease 2
• In patients ≥75 years or with renal insufficiency, strongly prefer topical NSAIDs over oral formulations 2
• Always co-prescribe a proton pump inhibitor with oral NSAIDs in elderly patients 3

Second-Line: Add Colchicine

If NSAIDs alone are insufficient after 1-2 weeks, add low-dose colchicine 1. This combination targets the inflammatory component more aggressively. The ACC guideline specifically mentions this approach for costochondritis-type chest pain, making it the highest-quality evidence for this specific condition.

Alternative and Adjunct Options

Acetaminophen (Paracetamol)

While not specifically studied for costochondritis, acetaminophen can be used for pain control in patients where NSAIDs are contraindicated 3, 5, 6. However, it lacks anti-inflammatory properties, making it less ideal as monotherapy for an inflammatory condition.

Corticosteroid Injections

Local corticosteroid injections directed at the affected costochondral junction may be considered for particularly troublesome or refractory cases 1, 7. A 2022 randomized controlled trial demonstrated that short-term oral corticosteroids (prednisolone 40mg daily for 1 week, then 20mg for 1 week, then 10mg for 1 week) combined with NSAIDs provided superior pain relief compared to NSAIDs alone 8. This represents the highest-quality evidence specific to costochondritis treatment, showing 46.8% vs 17.7% pain reduction at week 1 (p<0.001), with sustained benefit at 6.5 months follow-up.

Sulfasalazine for Recurrent Cases

For patients with recurrent costochondritis that repeatedly flares, consider sulfasalazine as a disease-modifying approach 9. A retrospective study showed 10 of 11 patients with recurrent symptoms responded to sulfasalazine after initial corticosteroid injection treatment.

Treatment Algorithm

1. Week 0-2: Start maximum tolerated dose NSAID (e.g., ibuprofen 600-800mg TID or naproxen 500mg BID)

   • Add PPI if age >65 or GI risk factors
   • Reassure patient about benign, self-limiting nature 6

2. Week 2: If insufficient response, add low-dose colchicine 1

3. Week 3-4: If still inadequate relief, consider:

   • Short course oral corticosteroids (prednisolone taper as above) 8, OR
   • Local corticosteroid injection to affected costochondral junction 1, 7

4. For recurrent cases: Consider sulfasalazine for long-term management 9

Critical Pitfalls to Avoid

• Do not miss cardiac causes: In patients >35 years or with cardiac risk factors, obtain ECG and consider cardiac workup before attributing pain to costochondritis 6. Coronary artery disease is present in 3-6% of patients with chest wall tenderness 6.

• Do not use systemic corticosteroids long-term: Short courses only (3 weeks maximum) 8

• Do not prescribe NSAIDs without gastroprotection in elderly: This population has the highest risk of serious GI bleeding 4

• Recognize that symptoms may persist: 55% of patients still have chest pain at 1 year, though only one-third have persistent costochondritis 10

The evidence strongly supports NSAIDs as first-line treatment, with the option to escalate to combination therapy with colchicine or short-term corticosteroids for refractory cases. Most cases are self-limiting within weeks to months 6, 11.